Cargando…
Validity of intraoperative voice monitoring undergoing type 2 thyroplasty with titanium bridges for adductor spasmodic dysphonia
OBJECTIVES: The success of type 2 thyroplasty (TP2) for adductor spasmodic dysphonia (AdSD) depends on the selection of optimally sized titanium bridges, which requires accurate assessment of intraoperative vocal changes. While this procedure has traditionally been performed according to the laryngo...
Autores principales: | Sanuki, Tetsuji, Oridate, Nobuhiko, Tateya, Ichiro, Nito, Takaharu, Mizoguchi, Kenji, Tanabe, Kenichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575097/ https://www.ncbi.nlm.nih.gov/pubmed/36258849 http://dx.doi.org/10.1002/lio2.898 |
Ejemplares similares
-
Optimizing Botox regimens in patients with adductor spasmodic dysphonia and essential tremor of voice: A 31‐year experience
por: Stone, Amy, et al.
Publicado: (2022) -
Effects of thyroplasty implant stiffness on glottal shape and voice acoustics
por: Cameron, Brian H., et al.
Publicado: (2019) -
Long‐term treatment outcome of type 1 thyroplasty using novel titanium medialization laryngoplasty implant combined with arytenoid adduction for unilateral vocal cord paralysis: single‐arm interventional study at a single institution
por: Sano, Daisuke, et al.
Publicado: (2020) -
Post‐treatment clinical course following botulinum toxin injection therapy for adductor spasmodic dysphonia: Analysis of data from a placebo‐controlled, randomized, double‐blinded clinical trial in Japan
por: Hirose, Kahori, et al.
Publicado: (2021) -
Tridimensional assessment of adductor spasmodic dysphonia pre- and post-treatment with Botulinum toxin
por: Dejonckere, P. H., et al.
Publicado: (2011)